Admission Date:  [**2118-9-9**]       Discharge Date: [**2118-9-10**]  Date of Birth:   [**2097-3-27**]       Sex:  M  Service:  BMT  HISTORY OF PRESENT ILLNESS:  31-year-old Vietnamese gentleman with chronic myelogenous leukemia in complete cytogenic remission here for allogeneic stem cell transplantation with his brother as a donor.
The patient has been maintained on Gleevec therapy 400 mg every day which was discontinued two days prior to admission.
The patient received Cardiology, Pulmonary, Infectious Disease, and Psychiatry evaluations prior to his transplant.
Infectious Disease recommended after engraftment the patient was to continue lamivudine 100 mg once per day for his hepatitis B.
Of note, the patient's pre-transplant hepatitis B DNA viral load was negative.
The patient is maintained on Gleevec therapy.
Asthma for which he takes and albuterol inhaler.
Albuterol inhaler as needed.
Anusol suppositories.
HEMATOLOGY/ONCOLOGY ISSUES:  The patient was followed transplant protocol receiving Cytoxan and then total body irradiation to be performed at [**Hospital6 1708**] followed by an allogeneic stem cell transplant with his brother as the donor.
INFECTIOUS DISEASE ISSUES:  The patient will need to be restarted on lamivudine 100 mg by mouth every day after engraftment for hepatitis B.
ACCESS ISSUES:  The patient has a left internal jugular and a right Hickman; both placed on [**9-9**], the day of admission.
FLUIDS/ELECTROLYTES/NUTRITION ISSUES:  Fluids per protocol, electrolyte replacement per sliding-scale, and a Bone Marrow Transplant diet of low bacteria.
